Meningococcal isolates from blood or cerebrospinal fluid submitted for culture confirmation and serotyping.
Meningococcal isolates from nasopharyngeal cultures or the contacts of patients with serious meningococcal infection, submitted for culture confirmation and serotyping.
Meningococcal isolates associated with an outbreak, submitted for culture confirmation and serotyping.
Isolates of Staphylococcus aureus associated with an outbreak, submitted for PFGE.
Isolates of penicillinase-producing Neisseria gonorrhoeae (PPNG) submitted for confirmation.
Isolates of Haemophilus influenza submitted for serotyping.
Isolates of Listeria monocytogenes submitted for serotyping.
Streptococcal isolates submitted for serotyping.
Isolates of Corynebacterium diphtheriae submitted for culture confirmation & toxigenicity testing.
Pharyngeal or nasopharyngeal smears submitted for identification of Bordetella pertussis by direct immunofluorescence.
Isolates of Salmonella/Shigella submitted for confirmation & serotyping.
Stools for culture from patients or food handlers involved in outbreaks of diarrheal diseases, if requested by the Health Department Bureaus of Environmental Investigation or Communicable Diseases.
Any outbreak related isolates for PFGE typing (prior arrangements need to be made by contracting the Molecular Typing Laboratory).
Isolates of Mycobacterium tuberculosis for susceptibility testing.
Respiratory specimens which are first-time smear positive for acid fast bacilli, submitted for MTD assay.
Rabies diagnostic tests.
Viral & rickettsial diagnostic tests for outbreak-related specimens submitted through the Bureaus of Communicable Diseases or Immunization Diseases.
Clinical and environmental specimens associated with potential botulism cases are submitted (after approval by the Bureau of Communicable Diseases) for the assay and identification of botulinal toxins.
Isolates submitted for BT testing and subsequently identified either as BT or other pathogens.